Skip Navigation Links
Centers for Disease Control and Prevention
nav image
nav image CDC Home Search Health Topics A-Z
Emergency Preparedness & Response Home What's New Search Contact Us
Emergency Preparedness & Response
Site-wide links
Emergency Preparedness & Response
Agents, Diseases, & Other Threats
•
Bioterrorism Agents
•
Chemical Agents
•
Mass Trauma
•
Natural Disasters
•
Radiation Emergencies
•
Recent Outbreaks & Incidents
Lab Information
Training
Preparation & Planning
Surveillance
Preparedness & Children
News
Related Links
En Español
Preparación y respuesta para casos de emergencia
Bioterrorism Agents >
Tularemia
español

On this page:

•

FAQs & Fact Sheets

•

Diagnosis/Evaluation

•

Treatment

•

Overviews

•

Laboratory Testing

•

Surveillance & Investigation

•

Infection Control
FAQs & Fact Sheets
• Key Facts About Tularemia (también en español)
Important information that can help you recognize & get treated for tularemia
• FAQ About Tularemia (también en español)

Diagnosis/Evaluation
• Diagnosis (from Abstract of "Consensus Statement: Tularemia as a Biological Weapon: Medical and Public Health Management")
Concise, bulleted summary of recommendations from the Working Group on Civilian Biodefense
Adobe Acrobat Reader PDF (214 KB/5 pages)

Full version of "Consensus Statement": Diagnosis
JAMA 1999;281(18):1735-1745.
Adobe Acrobat Reader PDF (340 KB/11 pages)

Treatment
• Treatment (from Abstract of "Consensus Statement: Tularemia as a Biological Weapon: Medical and Public Health Management")
Concise, bulleted summary of recommendations from the Working Group on Civilian Biodefense
Adobe Acrobat Reader PDF (214 KB/5 pages)

Full version of "Consensus Statement": Treatment
JAMA 1999;281(18):1735-1745.
Adobe Acrobat Reader PDF (340 KB/11 pages)

Overviews
• Video: "The History of Bioterrorism"
Describes the role of Category A agents—such as tularemia—as weapons of bioterrorism
• Abstract of "Consensus Statement: Tularemia as a Biological Weapon: Medical and Public Health Management"
Concise, bulleted summary of recommendations from the Working Group on Civilian Biodefense
Adobe Acrobat Reader PDF (214 KB/5 pages)

Full version of "Consensus Statement"
JAMA 1999;281(18):1735-1745.
Adobe Acrobat Reader PDF (340 KB/11 pages)
• Tularemia—United States, 1990-2000
MMWR 2002 Mar 8;51(9):182-184.
Adobe Acrobat Reader PDF (368 KB/24 pages)

Laboratory Testing
•

Basic Protocols for Level A Laboratories for the Presumptive Identification of Francisella tularensis Adobe Acrobat Reader PDF (203 KB/7 pages)
NOTE: Protocols for sentinel laboratories are no longer posted on the CDC website. The American Society for Microbiology has agreed to take the lead in the development & dissemination of sentinel laboratory information. Information for reference laboratories will continue to be available on the Laboratory Response Network secure website (for questions, e-mail lrn@cdc.gov; tollfree HelpDesk 1-866-LRN-LABS [1-866-576-5227]). The CDC subject matter experts on individual organisms remain available for discussion as always.
• Packaging Protocols for Biological Agents/Diseases Adobe Acrobat Reader PDF (61 KB/5 pages)
• Recognition of Illness Associated with the Intentional Release of a Biologic Agent
MMWR 2001 Oct 19;50(41):893-897.
Adobe Acrobat Reader PDF (168 KB/20 pages)

Surveillance & Investigation
• Epidemiology (from "Consensus Statement: Tularemia as a Biological Weapon: Medical and Public Health Management")
JAMA 1999;281(18):1735-1745.
Adobe Acrobat Reader PDF (340 KB/11 pages)
• Tularemia Surveillance Case Definitions
• Endemic, Notifiable Bioterrorism-Related Diseases, United States, 1992–1999
Emerging Infectious Diseases 2003 May;9(5):556-564.
Adobe Acrobat Reader PDF (291 KB/9 pages)
• Use of Automated Ambulatory-Care Encounter Records for Detection of Acute Illness Clusters, Including Potential Bioterrorism Events
Emerging Infectious Diseases 2002 Aug;8(8):753-760.
Adobe Acrobat Reader PDF (383 KB/8 pages)
• Recognition of Illness Associated with the Intentional Release of a Biologic Agent
MMWR 2001 Oct 19;50(41):893-897.
 Adobe Acrobat Reader PDF (168 KB/20 pages)

Infection Control
• Infection Control (from Abstract of "Consensus Statement: Tularemia as a Biological Weapon: Medical and Public Health Management")
Concise, bulleted summary of recommendations from the Working Group on Civilian Biodefense
Adobe Acrobat Reader PDF (214 KB/5 pages)

Full version of "Consensus Statement": Infection Control
JAMA 1999;281(18):1735-1745.
Adobe Acrobat Reader PDF (340 KB/11 pages)
•

Community-Based Mass Prophylaxis: A Planning Guide for Public Health Preparedness NEW! Oct 14, 2004
Planning guide to help state, county, & local officials meet federal requirements to prepare for public health emergencies. Outlines five components of mass prophylaxis response to epidemic outbreaks. Addresses dispensing operations using a comprehensive operational structure for Dispensing/Vaccination Centers (DVCs) based on the National Incident Management System (NIMS). (Developed by Weill Medical College of Cornell University for the Agency of Healthcare Research & Quality [AHRQ].)
• Recognition of Illness Associated with the Intentional Release of a Biologic Agent
MMWR 2001 Oct 19;50(41):893-897.
 Adobe Acrobat Reader PDF (168 KB/20 pages)

CDC HOTLINES

Public:
English—888-246-2675
Español—888-246-2857
TTY—866-874-2646
Clinicians:
877-554-4625
E-mail:
cdcresponse@ashastd.org
Related Resources
• Emerging Infectious Diseases
• MMWR
Top of Page


Home | What's New | Search | Contact Us

Page last modified October 14, 2004
   
    Home   |   Policies and Regulations   |   Disclaimer   |   Contact Us
Safer, Healthier People

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: 404-639-3311 | Public Inquiries: 888-246-2675 • español 888-246-2857 • TTY 866-874-2646		 FirstGovHHS Department of Health
and Human Services